Fintel reports that on October 25, 2024, Maxim Group initiated coverage of reAlpha Tech (NasdaqCM:AIRE) with a Buy ...

Fintel reports that on October 25, 2024, Maxim Group upgraded their outlook for Annovis Bio (NYSE:ANVS) from Hold to Buy. ...

Maxim Group has recently initiated Assertio Holdings Inc (ASRT) stock to Buy rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 3, 2024, H.C. Wainwright had initiated the ...

Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, ...

Maxim Group analyst Michael Diana maintained a Hold rating on Westamerica Bancorporation (WABC – Research Report) yesterday. The ...

Maxim Group initiated coverage on GameSquare Holdings Inc (NASDAQ: NASDAQ:GAME) with a Buy rating and a price target of $3.00. The firm cited the company's compelling valuation as a key reason for ...

Azitra to present at the 2024 Maxim Healthcare Virtual Summit, highlighting advancements in precision dermatology therapies.

Maxim (NASDAQ:MXIM) Group initiated coverage on GameSquare Holdings Inc (NASDAQ: NASDAQ:GAME) with a Buy rating and a price target of $3.00. The firm cited the company's compelling valuation as a key ...

Tuesday, Maxim (NASDAQ:MXIM) Group began coverage on shares of Ocugen, Inc. (NASDAQ: NASDAQ:OCGN), issuing a Buy rating and setting a price target of $4.00. The firm highlighted Ocugen's financial ...

On Tuesday, Beyond Inc (BYON) stock saw a modest uptick, ending the day at $10.34 which represents a slight increase of $0.17 or 1.67% from the prior close of $10.17. The stock opened at $10.2 and ...

Fintel reports that on October 16, 2024, Maxim Group downgraded their outlook for Helius Medical Technologies (MUN:26H) from Buy to Hold. There are 19 funds or institutions reporting positions in ...